LDHB and hepatocellular carcinoma: On the other hand, the IPS (CTLA4_pos_PD1_neg, CTLA4_neg_PD1_pos and CTLA4_pos_PD1_pos) were low in the LDHB high methylation group (Fig. 5B), indicating that LDHB could affect the immunotherapy response of HCC patients.